What are biosimilars? Which patient groups receive them? And which active pharmaceutical ingredients are available? All this and more will be explained here. Furthermore, you will find out what biosimilars mean to the health care system – and how we profit from them. You will receive information on why it is important that doctors prescribe and switch to biosimilars. As well as why it could become critical if, with the introduction of automatic substitution, pharmacists could decide over the preparation to be dispensed.
